ARCHIVES

BRCA1 and BRCA2 Mutations Linked To Higher Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

NCI “Can’t Justify Size Of Intramural Program”

May 12, 1995

PET Tracer Drug Approved, Developed At Weill Cornell

September 24, 2004

In Brief: CRCC, One Of The 21 Comprehensive Centers, To Close Up; Steckel New AACI President

January 30, 1981

Health Organizations Endorse “Patients’ Rights” Document

November 17, 1995

NIH Balks At Forming New Review Groups For NCI’s Program Grants; Guidelines Draft Ready For NCAB

August 2, 1974

Greatest Need Of Cancer Care Givers: “Will to Work Together,” ACCC President Anderson Says

August 15, 1986